Trifast PLC Director/PDMR Shareholding

RNS Number : 7333P

Trifast PLC

11 December 2024

 

 

 

Wednesday, 11 December 2024

 

Trifast plc

(the "Company")

 

Director/PDMR Shareholding

 

The Company has been informed that certain investment vehicles connected with Nicholas Mills, a Director of the Company have purchased 297,112 Ordinary Shares at a price of 81p per Ordinary Share on 5 December 2024.

 

Following the purchase, Nicholas Mills and the investment vehicles connected with him are interested in 20,685,000 Ordinary Shares, representing 15.196% of the Company's issued share capital.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Rockwood Strategic Plc, PCA to Nicholas Mills
2	Reason for the notification
a)	Position/status	PCA to PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Trifast plc
b)	LEI	213800WFIVE6RWK3CR22
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 5p each
	Identification code	GB0008883927
b)	Nature of the transaction	Share purchase
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£0.81	297,112
d)	Aggregated information
	- Aggregated volume	297,112
	- Price	£240,660.72
e)	Date of the transaction	5 December 2024
f)	Place of the transaction	London Stock Exchange

 

 

Enquiries:

Trifast plc

Christopher Morgan

Company Secretary

Tel: [phone]

www.trifast.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHKZMMZFMMGDZM